GLP-1 receptor agonists are intended for adults with obesity (BMI 30) or those who are overweight (BMI 27) with associated metabolic conditions such as hypertension, dyslipidaemia, or type 2 diabetes
Coverage varies significantly between insurers and policy types, so contact your insurer directly to confirm whether Wegovy is covered under your plan
However, it should be noted that a low-FODMAP diet may lead to insufficient fiber intake, which could exacerbate constipation in some IBS-C patients, so individual adjustments are necessary
Our Iron Boost IV therapy is precision-engineered to replenish iron levels, enhance oxygen transport, and revitalize your energy stores
Hunter A, Regnard C, Armstrong C